B
Bruce G. Bender
Researcher at National Jewish Health
Publications - 223
Citations - 11550
Bruce G. Bender is an academic researcher from National Jewish Health. The author has contributed to research in topics: Asthma & Health care. The author has an hindex of 53, co-authored 212 publications receiving 10642 citations. Previous affiliations of Bruce G. Bender include Stanford University & Anschutz Medical Campus.
Papers
More filters
Journal ArticleDOI
Long-term effects of budesonide or nedocromil in children with asthma.
Stanley J. Szefler,Scott T. Weiss,James Tonascia,N. Franklin Adkinson,Bruce G. Bender,Reuben M. Cherniack,Michele Donithan,H William Kelly,J. Reisman,Gail G. Shapiro,Alice L. Sternberg,R.C. Strunk,Virginia S. Taggart,Mark L. Van Natta,Robert A. Wise,Margaret Wu,Robert S. Zeiger +16 more
TL;DR: In children with mild-to-moderate asthma, neither budesonide nor nedocromil is better than placebo in terms of lung function, but inhaled budesonides improves airway responsiveness and provides better control of asthma than placebo or nedOCromil.
Journal ArticleDOI
Noncompliance and treatment failure in children with asthma
TL;DR: Electronic monitoring demonstrated much lower adherence to prescribed therapy than was reported by patients on diary cards, and low rates of compliance with prescribed inhaled corticosteroids were associated with exacerbation of disease.
Journal ArticleDOI
Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT.
Bruce G. Bender,Frederick S. Wamboldt,Shannon L. O'Connor,Cynthia S. Rand,Stanley J. Szefler,Henry Milgrom,Marianne Z. Wamboldt +6 more
TL;DR: Electronic adherence monitoring was significantly more accurate than self-report or canister weight measures and was an essential prerequisite to increasing understanding of the treatment, setting, and patient factors that influence adherence and to the consequent design of effective intervention strategies.
Journal ArticleDOI
Nonadherence in asthmatic patients : is there a solution to the problem?
TL;DR: Improved adherence will lead to improved disease control, but only if medical care systems encourage and support the allocation of sufficient resources to allow barriers to self-management to be discussed and solutions negotiated.
Journal ArticleDOI
Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires.
Bruce G. Bender,Sarah E. Bender +1 more
TL;DR: The most common barriers to adherence revealed by patients included concerns about drug safety and cost, and a belief that the patient's asthma was not severe enough to require daily treatment.